217 related articles for article (PubMed ID: 24413257)
1. Diorganotin(IV) derivatives of substituted N-hydroxybenzamides with selective cytotoxicity in vitro and potent antitumor activity in vivo.
Li YL; Wang ZW; Guo P; Tang L; Ge R; Ban SR; Chai QY; Niu L; Li QS
J Inorg Biochem; 2014 Apr; 133():1-7. PubMed ID: 24413257
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of a new mixed-ligand complex di-n-butyl-(4-chlorobenzohydroxamato)tin(IV) chloride.
Li Y; Li Y; Niu X; Jie L; Shang X; Guo J; Li Q
J Inorg Biochem; 2008 Sep; 102(9):1731-5. PubMed ID: 18573534
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxic activity of novel protoflavone analogs - selectivity towards a multidrug resistant cancer cell line.
Danko B; Martins A; Chuang DW; Wang HC; Amaral L; Molnár J; Chang FR; Wu YC; Hunyadi A
Anticancer Res; 2012 Jul; 32(7):2863-9. PubMed ID: 22753749
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic activity of diorganotin(IV) complexes of some xanthate derivatives.
Rashan LJ; al-Allaf TA; Khuzaie RF
Boll Chim Farm; 1995 Sep; 134(8):464-6. PubMed ID: 7576446
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structural characterization and in vitro cytotoxicity of diorganotin (IV) diimido complexes.
Yin H; Yue C; Hong M; Cui J; Wu Q; Zhang X
Eur J Med Chem; 2012 Dec; 58():533-42. PubMed ID: 23164659
[TBL] [Abstract][Full Text] [Related]
6. Diorganotin(IV) derivatives of substituted benzohydroxamic acids with high antitumor activity.
Li Q; da Silva MF; Pombeiro AJ
Chemistry; 2004 Mar; 10(6):1456-62. PubMed ID: 15034889
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxicity evaluation of novel podophyllotoxin derivatives.
Chengniu W; Zhonghua W; Yu Z; Chunyan N; Xiaodong Z; Li Z
Arch Pharm (Weinheim); 2011 Nov; 344(11):735-40. PubMed ID: 21887802
[TBL] [Abstract][Full Text] [Related]
8. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antitumor activities of lupeol dicarboxylic acid monoester derivatives.
Li W; Hao J; Xiao Y
Arch Pharm Res; 2013 Dec; 36(12):1447-53. PubMed ID: 23700293
[TBL] [Abstract][Full Text] [Related]
11. Biological characterization of the antiproliferative potential of Co(II) and Sn(IV) coordination compounds in human cancer cell lines: a comparative proteomic approach.
Silva A; Luís D; Santos S; Silva J; Mendo AS; Coito L; Silva TF; da Silva MF; Martins LM; Pombeiro AJ; Borralho PM; Rodrigues CM; Cabral MG; Videira PA; Monteiro C; Fernandes AR
Drug Metabol Drug Interact; 2013; 28(3):167-76. PubMed ID: 23800656
[TBL] [Abstract][Full Text] [Related]
12. Novel di-n-butyltin(IV) derivatives: Synthesis, high levels of cytotoxicity in tumor cells and the induction of apoptosis in KB cancer cells.
Shang X; Ding N; Xiang G
Eur J Med Chem; 2012 Feb; 48():305-12. PubMed ID: 22226547
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer activity of some novel 2-phenazinamine derivatives.
Gao X; Lu Y; Fang L; Fang X; Xing Y; Gou S; Xi T
Eur J Med Chem; 2013 Nov; 69():1-9. PubMed ID: 23995213
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferation inhibition and antitumor activity of novel alkyl series of diorganotin(IV) compounds.
Koch B; Baul TS; Chatterjee A
J Appl Toxicol; 2008 May; 28(4):430-8. PubMed ID: 17668440
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
16. Novel rotundic acid derivatives: synthesis, structural characterization and in vitro antitumor activity.
Chen Y; He YF; Nan ML; Sun WY; Hu J; Cui A; Li F; Wang F
Int J Mol Med; 2013 Feb; 31(2):353-60. PubMed ID: 23233042
[TBL] [Abstract][Full Text] [Related]
17. Antitumor agents 292. Design, synthesis and pharmacological study of S- and O-substituted 7-mercapto- or hydroxy-coumarins and chromones as potent cytotoxic agents.
Chen Y; Liu HR; Liu HS; Cheng M; Xia P; Qian K; Wu PC; Lai CY; Xia Y; Yang ZY; Morris-Natschke SL; Lee KH
Eur J Med Chem; 2012 Mar; 49():74-85. PubMed ID: 22265685
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms by which the antitumor compound di-n-butyl-di-(4-chlorobenzohydroxamato)tin(IV) induces apoptosis and the mitochondrial-mediated signaling pathway in human cancer SGC-7901 cells.
Li Y; Liu J; Li Q
Mol Carcinog; 2010 Jun; 49(6):566-81. PubMed ID: 20336762
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic and anticancer effects of the triorganotin compound [(C₆H₅)₃Sn(cmbzt)]: an in vitro, ex vivo and in vivo study.
Metsios A; Verginadis I; Simos Y; Batistatou A; Peschos D; Ragos V; Vezyraki P; Evangelou A; Karkabounas S
Eur J Pharm Sci; 2012 Sep; 47(2):490-6. PubMed ID: 22841513
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
